Clincosm LogoSign in Get a demo

allogeneic stem cell transplant

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • Allogeneic Stem Cell Transplant
  • App
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Allogeneic Stem Cell Transplant, Viral Infection, Viral Reactivation Trial in Cincinnati (Viral specific VST Infusion)

Recruiting
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Viral specific VST Infusion
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 15, 2022

Acute Graft-versus-Host Disease

Active, not recruiting
  • Acute Graft-versus-Host Disease
  • Allogeneic Stem Cell Transplant
  • Blood samples
  • Columbus, Ohio
    Ohio State University Medical Center
Apr 18, 2022

Allogeneic Stem Cell Transplant, Viral Infection Trial in Cincinnati (Viral Specific T-cells (VSTs))

Active, not recruiting
  • Allogeneic Stem Cell Transplant
  • Viral Infection
  • Viral Specific T-cells (VSTs)
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
May 5, 2021

Acute GVHD Grade II-IV, Allogeneic Stem Cell Transplant, Acute Myeloid Leucaemia Trial in Leuven, Nijmegen (alternate dosing,

Completed
  • Acute Graft Versus Host Disease Grade II-IV
  • +3 more
  • alternate dosing
  • +2 more
  • Leuven, Belgium
  • +1 more
Dec 4, 2020

Allogeneic Stem Cell Transplant, Acute GVHD, Acute Myeloid Leucaemia Trial in Leuven, Nijmegen (posaconazole)

Completed
  • Allogeneic Stem Cell Transplant
  • +3 more
  • Leuven, Belgium
  • +1 more
Dec 13, 2019

Hematopoietic Cell Transplantation (HCT)

Completed
Has Results
  • Allogeneic Stem Cell Transplant
  • +3 more
    • (no location specified)
    Sep 26, 2019

    Allogeneic Stem Cell Transplant, Leukemia, Non-Hodgkins Trial in New York (cytoreductive regimen followed by a CD34+E- selected

    Completed
    Has Results
    • Allogeneic Stem Cell Transplant
    • +5 more
    • cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jan 20, 2017

    Haematological Malignancies, Allogeneic Stem Cell Transplant, CD56+CD3- NK Cells Trial in London (Infusion of donor derived

    Withdrawn
    • Haematological Malignancies
    • +2 more
    • Infusion of donor derived ex-vivo selected NK cells to patients after transplant
    • Haematology / Blood chemistry sampling
    • London, United Kingdom
      Hammersmith Hospital
    Jun 3, 2015